Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
60,563.00
55,407.00
51,015.00
49,632.00
49,253.00
46,902.00
46,074.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
60,563.00
55,407.00
51,015.00
49,632.00
49,253.00
46,902.00
46,074.00
Raw Material Cost
44,372.00
41,889.00
37,654.00
36,722.00
35,629.00
34,607.00
33,147.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
7,762.00
7,635.00
7,710.00
7,639.00
7,481.00
7,223.00
7,186.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
161.00
171.00
165.00
176.00
196.00
224.00
226.00
Selling and Distribution Expenses
10,341.00
10,084.00
9,801.00
9,544.00
9,811.00
9,875.00
9,901.00
Other Expenses
-620.50
-633.70
-652.20
-637.30
-621.50
-603.80
-564.80
Total Expenditure (Excl Depreciation)
56,431.00
53,442.00
48,808.00
47,708.00
46,902.00
45,891.00
44,812.00
Operating Profit (PBDIT) excl Other Income
4132
1965
2207
1924
2351
1011
1262
Other Income
-280.00
14.00
82.00
82.00
104.00
192.00
107.00
Operating Profit (PBDIT)
5,678.00
3,709.00
4,548.00
4,386.00
4,708.00
3,392.00
3,336.00
Interest
161.00
171.00
165.00
176.00
196.00
224.00
226.00
Exceptional Items
-8,660.00
-39.00
83.00
83.00
87.00
60.00
113.00
Gross Profit (PBDT)
16,191.00
13,518.00
13,361.00
12,910.00
13,624.00
12,295.00
12,927.00
Depreciation
1,826.00
1,730.00
2,259.00
2,380.00
2,253.00
2,189.00
1,967.00
Profit Before Tax
-4,970.00
1,767.00
2,205.00
1,911.00
2,345.00
1,042.00
1,255.00
Tax
-1,682.00
389.00
599.00
427.00
737.00
335.00
361.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-3,288.00
1,377.00
1,605.00
1,483.00
1,607.00
707.00
894.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-3,288.00
1,377.00
1,605.00
1,483.00
1,607.00
707.00
894.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-3,288.00
1,377.00
1,605.00
1,483.00
1,607.00
707.00
894.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
33,043.00
36,661.00
35,649.00
34,532.00
33,683.00
32,302.00
32,842.00
Earnings per share (EPS)
-384.9
159.92
182.99
169.05
183.16
80.57
101.86
Diluted Earnings per share
-384.9
159.92
182.99
169.05
183.16
80.57
101.86
Operating Profit Margin (Excl OI)
6.82%
3.55%
4.33%
3.88%
4.77%
2.16%
2.74%
Gross Profit Margin
-5.19%
6.31%
8.75%
8.65%
9.34%
6.89%
6.99%
PAT Margin
-5.43%
2.49%
3.15%
2.99%
3.26%
1.51%
1.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 9.31% vs 8.61% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -338.78% vs -14.21% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 61.24% vs -17.26% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.85% vs 3.64% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Fuso Pharmaceutical Industries Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
60,563.00
7.59
60,555.41
797,831.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
60,563.00
7.59
60,555.41
797,831.49%
Raw Material Cost
44,372.00
0.20
44,371.80
22,185,900.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
7,762.00
239.51
7,522.49
3,140.78%
Power Cost
0
0
0.00
Manufacturing Expenses
161.00
0.00
161.00
Selling and Distribution Expenses
10,341.00
496.70
9,844.30
1,981.94%
Other Expenses
-620.50
34.04
-654.54
-1,922.86%
Total Expenditure (Excl Depreciation)
56,431.00
1,076.77
55,354.23
5,140.77%
Operating Profit (PBDIT) excl Other Income
4,132.00
-1,069.18
5,201.18
486.46%
Other Income
-280.00
107.15
-387.15
-361.32%
Operating Profit (PBDIT)
5,678.00
-962.04
6,640.04
690.20%
Interest
161.00
0.00
161.00
Exceptional Items
-8,660.00
0.00
-8,660.00
Gross Profit (PBDT)
16,191.00
7.39
16,183.61
218,993.37%
Depreciation
1,826.00
0.00
1,826.00
Profit Before Tax
-4,970.00
-962.03
-4,007.97
-416.62%
Tax
-1,682.00
2.42
-1,684.42
-69,604.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
-3,288.00
-964.46
-2,323.54
-240.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-3,288.00
-964.46
-2,323.54
-240.92%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-3,288.00
-964.46
-2,323.54
-240.92%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
33,043.00
4,725.50
28,317.50
599.25%
Earnings per share (EPS)
-384.90
-22.28
-362.62
-1,627.56%
Diluted Earnings per share
-384.90
-22.28
-362.62
-1,627.56%
Operating Profit Margin (Excl OI)
6.82%
-14,092.29%
0.00
14,099.11%
Gross Profit Margin
-5.19%
-12,680.04%
0.00
12,674.85%
PAT Margin
-5.43%
-12,711.94%
0.00
12,706.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6,056.30 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 9.31% vs 8.61% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -328.80 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -338.78% vs -14.21% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 595.80 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 61.24% vs -17.26% in Mar 2024
Annual - Interest
Interest 16.10 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -5.85% vs 3.64% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.82%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






